Herrera; Victoria L. M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Herrera; Victoria L. M..The latest application filed is for "anti-despr inhibitors as therapeutics for inhibition of pathological angiogenesis and tumor cell invasiveness and for molecular imaging and targeted delivery".

Company Profile

2.9.17

Herrera; Victoria L. M. - Westwood MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-DEspR monoclonal antibody targeted therapy and imaging for cancer and stroke Grant 11,236,169 - Ruiz-Opazo , et al. February 1, 2	2022-02-01
ANTI-DEspR INHIBITORS AS THERAPEUTICS FOR INHIBITION OF PATHOLOGICAL ANGIOGENESIS AND TUMOR CELL INVASIVENESS AND FOR MOLECULAR IMAGING AND TARGETED DELIVERY App 20210155700 - Ruiz-Opazo; Nelson ; et al.	2021-05-27
Methods For Treating Netosis And Neutrophil Activation App 20210121549 - RUIZ-OPAZO; Nelson ; et al.	2021-04-29
Anti-DEspR inhibitors as therapeutics for inhibition of pathological angiogenesis and tumor cell invasiveness and for molecular imaging and targeted delivery Grant 10,934,358 - Ruiz-Opazo , et al. March 2, 2	2021-03-02
Methods for treating netosis and neutrophil activation Grant 10,849,966 - Ruiz-Opazo , et al. December 1, 2	2020-12-01
Theranostic compositions and uses thereof Grant 10,568,970 - Wong , et al. Feb	2020-02-25
brANTI-DEspR MONOCLONAL ANTIBODY TARGETED THERAPY AND IMAGING FOR CANCER AND STROKE App 20190153106 - Ruiz-Opazo; Nelson ; et al.	2019-05-23
ANTI-DEspR INHIBITORS AS THERAPEUTICS FOR INHIBITION OF PATHOLOGICAL ANGIOGENESIS AND TUMOR CELL INVASIVENESS AND FOR MOLECULAR IMAGING AND TARGETED DELIVERY App 20190092865 - Ruiz-Opazo; Nelson ; et al.	2019-03-28
Methods For Treating Netosis And Neutrophil Activation App 20190083595 - Ruiz-Opazo; Nelson ; et al.	2019-03-21
Anti-DEspR monoclonal antibody targeted therapy and imaging for cancer and stroke Grant 10,202,457 - Ruiz-Opazo , et al. Feb	2019-02-12
Anti-DEspR inhibitors as therapeutics for inhibition of pathological angiogenesis and tumor cell invasiveness and for molecular imaging and targeted delivery Grant 10,040,856 - Ruiz-Opazo , et al. August 7, 2	2018-08-07
Theranostic Compositions And Uses Thereof App 20180028683 - Wong; Joyce Y. ; et al.	2018-02-01
ANTI-DEspR MONOCLONAL ANTIBODY TARGETED THERAPY AND IMAGING FOR CANCER AND STROKE App 20170058036 - Ruiz-Opazo; Nelson ; et al.	2017-03-02
ANTI-DEspR INHIBITORS AS THERAPEUTICS FOR INHIBITION OF PATHOLOGICAL ANGIOGENESIS AND TUMOR CELL INVASIVENESS AND FOR MOLECULAR IMAGING AND TARGETED DELIVERY App 20160108124 - Ruiz-Opazo; Nelson ; et al.	2016-04-21
Roles for Dual Endothelin-1/Angiotensin II Receptor (Dear) in hypertension and angiogenesis Grant 8,956,609 - Herrera , et al. February 17, 2	2015-02-17
Roles For Dual Endothelin-1/angiotensin Ii Receptor (dear) In Hypertension And Angiogenesis App 20140186344 - HERRERA; Victoria L.M. ; et al.	2014-07-03
Anti-despr Inhibitors As Therapeutics For Inhibition Of Pathological Angiogenesis And Tumor Cell Invasiveness And For Molecular Imaging And Targeted Delivery App 20130177500 - Ruiz-Opaz; Nelson ; et al.	2013-07-11
DEspR ANTAGONISTS AND AGONISTS AS THERAPEUTICS App 20130022551 - Ruiz-Opazo; Nelson ; et al.	2013-01-24
Roles For Dual Endothelin-1/angiotensin Ii Receptor (dear) In Hypertension And Angiogenesis App 20110142821 - HERRERA; Victoria L.M. ; et al.	2011-06-16
Roles for dual endothelin-1/angiotensin II receptor (Dear) in hypertension and angiogenesis Grant 7,919,093 - Herrera , et al. April 5, 2	2011-04-05
Roles For Dual Endothelin-1/Angiotensin II Receptor (DEAR) In Hypertension and Angiogenesis App 20090028852 - Herrera; Victoria L.M. ; et al.	2009-01-29
Method of assaying modulators of hypertension Grant 6,844,483 - Ruiz-Opazo , et al. January 18, 2	2005-01-18
Animal models for cardiac disease App 20030140357 - Herrera, Victoria L. M. ; et al.	2003-07-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.